News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 728
- Sources here
- 21
- Companies here
- 11
Active search
728 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CFO Awards honoree Frank Stokes of Castle Biosciences Inc.
Frank Stokes of Castle Biosciences Inc. has been recognized as an honoree for the Houston Business Journal's 2026 CFO Awards. The article highlights Stokes as one of several distinguished individuals acknowledged for their financial leadership. Other honorees include Frank Wilson IV, Ebru Akyildiz, Stephanie …
Is Crown Castle (CCI) Undervalued On Earnings And Buybacks?
Crown Castle (CCI) reported its second-quarter 2026 results and an update on share repurchases, sparking discussion about its valuation. Despite a 14% drop in stock price over 90 days and a 25% decrease in the 1-year total shareholder return, the company is considered 20.6% …
Castle Biosciences 2026: Revenue $103.55M, EPS ($0.07) — 10-Q Summary
Castle Biosciences (CSTL) reported its 2026 financial results, showing revenue of $103.55 million, an increase from $86.19 million in the previous year. However, the company posted a net loss of ($2.06 million) and diluted EPS of ($0.07), a decline from the prior year's net …
Beasley Broadcast Group, Inc. Revenue Breakdown – NASDAQ:BBGI
This article provides a revenue breakdown for Beasley Broadcast Group, Inc. (NASDAQ:BBGI), highlighting that the United States was the primary contributor to its revenue in recent years. The company generated $205.94 million USD last year from the U.S., down from $240.29 million USD the …
Castle Biosciences, Inc. Stock 12‑Month Price Target Raised to $43.56, Implies 63% Upside
Castle Biosciences, Inc. (CSTL) has seen its average 12-month price target raised to $43.56 from $42.78 by 9 analysts, implying a potential upside of approximately 63% from its July 30 closing price. The consensus rating for the stock remains a "Buy" across all covering …
Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share
Nexstar Media Group, Inc. (NASDAQ: NXST) announced that its Board of Directors declared a quarterly cash dividend of $1.86 per share of its common stock. The dividend is payable on August 28, 2026, to shareholders of record on August 14, 2026. The company intends …
Janus Henderson Group PLC Boosts Holdings in Nexstar Media Group, Inc. $NXST
Janus Henderson Group PLC increased its stake in Nexstar Media Group, Inc. by 1.8% in the first quarter, now owning 643,864 shares valued at $116.4 million. Institutional investors hold 95.3% of NXST, while company insiders have sold 22,813 shares totaling $4.17 million over the …
5 Must-Read Analyst Questions From Comcast’s Q2 Earnings Call
5 Must-Read Analyst Questions From Comcast's Q2 Earnings Call Comcast's second quarter results were marked by a mix of progress and ongoing challenges, with the company surpassing Wall Street's revenue and profit expectations but facing a negative market reaction. Management highlighted steady gains in …
Sharemaestro market context Price below Trend Line 52 weeks -29.9%Amundi Raises Stock Holdings in Crown Castle Inc. $CCI
Amundi increased its stake in Crown Castle Inc. (NYSE:CCI) by 2.1% in the first quarter of 2026, acquiring an additional 39,371 shares to hold a total of 1.96 million shares valued at approximately $159.2 million. Other institutional investors also adjusted their positions in the …
CSTL (CSTL) insider schedules potential $630,000 sale of 22,500 shares
An affiliate of CASTLE BIOSCIENCES INC (CSTL) has filed a Form 144 to sell 22,500 shares of common stock, with an aggregate market value of $630,000. The shares, originating from various equity compensation grants including Restricted Stock Units and Restricted Stock Awards, are scheduled …
Form 144 Castle Biosciences For: 1 August By Investing.com
This article announces the filing of Form 144 for Castle Biosciences (CSTL) on August 1st. It provides a brief mention of the company's stock performance, showing a 4.52% increase. The content largely consists of market data, trending stocks, and various financial tools provided by …
Nexstar Media Group Declares Quarterly Cash Dividend
Nexstar Media Group announced a quarterly cash dividend of $1.86 per share, payable on August 28, 2026, to shareholders of record as of August 14, 2026. This dividend reflects the company's profitability and commitment to shareholder returns, with plans to continue quarterly dividends subject …
Nexstar sets Aug. 14 cutoff for shareholders to get $1.86
Nexstar Media Group (NASDAQ: NXST) announced a quarterly cash dividend of $1.86 per share, payable on August 28, 2026. Shareholders of record by August 14, 2026, will be eligible for the dividend. The company stated its intention to continue regular quarterly cash dividends, subject …
Castle Biosciences (CSTL) Stock Climbs On Higher Sales Outlook Despite Margin Pressure
Castle Biosciences (CSTL) stock saw a 4.5% jump after its Q2 earnings report, driven by a 20% revenue increase to US$103.5m and an uplifted full-year sales guidance, despite reporting a small net loss. The market appears to be prioritizing the strong top-line growth and …
Comcast Completes High-Speed Network Expansion to Waterbury, Bringing Advanced Technology Solutions to Businesses of All Sizes
Comcast has completed a high-speed network expansion in Waterbury, Connecticut, providing businesses in the downtown area with advanced technology solutions including symmetrical internet, cybersecurity, and mobile services. This expansion aims to boost the local economy by offering reliable, scalable connectivity up to 100 Gbps, …
Sharemaestro market context Price below Trend Line 52 weeks -29.9%NXST|Nexstar Media Group Inc|Price:192.490|Chg%:-4.450
Nexstar Media Group Inc. (NXST) exhibits stable fundamentals and high growth potential, with its valuation considered fairly priced within the Media & Publishing industry. Institutional ownership is high, and analysts have consistently rated it as a "Buy" with a target price of $251.54. The …
Queen City News, Nexstar to host GOP U.S. Senate Debate Aug. 4 ahead of South Carolina primary
Queen City News and Nexstar Media Group will host a live, one-hour debate on August 4 for Republican candidates vying for South Carolina's U.S. Senate seat. Five candidates are invited, though interim U.S. Senator Darline Graham will be absent due to Senate business. The …
Orographic Financial Advisors LLC Invests $1.51 Million in Crown Castle Inc. $CCI
Orographic Financial Advisors LLC has initiated a new position in Crown Castle Inc. (NYSE:CCI), acquiring 18,573 shares valued at approximately $1.51 million. This investment highlights continued institutional interest in Crown Castle, with other major investors also adjusting their holdings. The stock currently offers a …
Nexstar to host exclusive live debate in South Carolina GOP special primary
Nexstar Media Group announced it will host an exclusive live debate for candidates seeking the Republican Primary Party’s nomination for the U.S. Senate seat in South Carolina vacated by the late Lindsey Graham. The debate, titled “Debate Night in South Carolina,” will take place …
California State Teachers Retirement System Trims Stock Position in Crown Castle Inc. $CCI
The California State Teachers Retirement System reduced its stake in Crown Castle Inc. by 2.6% in the first quarter, selling 18,952 shares but retaining 711,707 shares valued at $57.9 million. Institutional investors now own 90.77% of the real estate investment trust. Analysts generally have …
Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth
Earnings Call Insights: Castle Biosciences (CSTL) Q2 2026 MANAGEMENT VIEW * "What a great quarter." (Founder, CEO, President & Director Derek Maetzold) "We delivered revenue of $103.5 million, 20% growth compared to the second quarter of 2025." (CEO Maetzold) * "We believe we will …
Key facts: CSTL Q2 Revenue $103.6M; AdvanceAD-Tx 97.8% Concordance
Castle Biosciences (CSTL) reported Q2 revenue of $103.55 million, exceeding estimates of $86.2 million, despite an operating loss of $3.07 million. Additionally, a study revealed that the company's AdvanceAD-Tx testing for atopic dermatitis showed a 97.8% concordance in systemic therapy decisions, significantly higher than …
Public Notice: Arium Networks (Crown Castle) is proposing to install a new 32.0-foot replacement telecommunications light pole utility structure within the public right of way located at the following site: 10617 West Solano Drive, Glendale, Maricopa County, Ari
Arium Networks, a subsidiary of Crown Castle, is proposing to install a new 32.0-foot telecommunications light pole in Glendale, Arizona. The company is seeking comments from interested parties regarding the potential impact of the project on historical or cultural sites, as well as the …
Castle Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CSTL)
Castle Biosciences, Inc. released its Q2 2026 earnings call presentation. The company reported an EPS of -$0.07, beating estimates by $0.34, and revenue of $103.55M, an increase of 20.14% year-over-year, beating estimates by $17.30M. This report accompanies their earnings call from July 31, 2026.
Comcast (CMCSA) Expands Universal Ads With New Measurement Partners For Premium TV
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Comcast expanded its Universal Ads platform with new Audience and Mobile Measurement Partners. The …
Sharemaestro market context Price below Trend Line 52 weeks -29.9%Comcast Corp (CMCSA) Shares Fall 3.8% -- What GF Score of 63 Tel
Comcast Corp (CMCSA) shares dropped 3.8% to $23.67, yet GuruFocus's GF Value™ estimates its fair value at $37.59, indicating it is 37.0% undervalued. Despite a GF Score™ of 63/100, highlighting strong profitability (8/10), the stock carries a "Possible Value Trap" warning due to weaker …
Sharemaestro market context Price below Trend Line 52 weeks -115.8%Earnings call transcript: Castle Biosciences tops Q2 2026 estimates, shares jump
Castle Biosciences (CSTL) exceeded second-quarter 2026 profit and revenue estimates, leading to a significant jump in its share price and an increase in full-year sales guidance. The company reported an adjusted loss of 7 cents per share on revenue of $103.5 million, outperforming analyst …
Crown Castle Inc. stock underperforms Thursday when compared to competitors
Shares of Crown Castle Inc. (CCI) fell 3.26% on Thursday, closing at $76.51. This underperformance occurred on a positive trading day for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. The stock's decline ended a …